Validation of a novel risk score to predict early and late recurrence in solitary fibrous tumour

Autor: Tatiana Georgiesh, Ninna Aggerholm-Pedersen, Patrick Schöffski, Yifan Zhang, Andrea Napolitano, Judith V. M. G. Bovée, Åse Hjelle, Gordon Tang, Mateusz Spalek, Margherita Nannini, David Swanson, Thomas Baad-Hansen, Raf Sciot, Asle C. Hesla, Paul Huang, Desiree Dorleijn, Hans Kristian Haugland, Maribel Lacambra, Jacek Skoczylas, Maria A. Pantaleo, Rick L. Haas, Leonardo A. Meza-Zepeda, Florian Haller, Anna M. Czarnecka, Herbert Loong, Nina L. Jebsen, Michiel van de Sande, Robin L. Jones, Felix Haglund, Iris Timmermans, Akmal Safwat, Bodil Bjerkehagen, Kjetil Boye

Publikováno v: British Journal of Cancer, 127(10), 1793-1798. SPRINGERNATURE
Georgiesh, T, Aggerholm-Pedersen, N, Schoffski, P, Zhang, Y, Napolitano, A, Bovee, J V M G, Hjelle, A, Tang, G, Spalek, M, Nannini, M, Swanson, D, Baad-Hansen, T, Sciot, R, Hesla, A C, Huang, P, Dorleijn, D, Haugland, H K, Lacambra, M, Skoczylas, J, Pantaleo, M A, Haas, R L, Meza-Zepeda, L A, Haller, F, Czarnecka, A M, Loong, H, Jebsen, N L, van de Sande, M, Jones, R L, Haglund, F, Timmermans, I, Safwat, A, Bjerkehagen, B & Boye, K 2022, ' Validation of a novel risk score to predict early and late recurrence in solitary fibrous tumour ', British Journal of Cancer, vol. 127, pp. 1793–1798 . https://doi.org/10.1038/s41416-022-01959-4

Background: Current risk models in solitary fibrous tumour (SFT) were developed using cohorts with short follow-up and cannot reliably identify low-risk patients. We recently developed a novel risk model (G-score) to account for both early and late r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd25bb81e20bc049c2f5369780ede4b8
https://doi.org/10.1038/s41416-022-01959-4

Selpercatinib in Patients With

Autor: Alexander, Drilon, Vivek, Subbiah, Oliver, Gautschi, Pascale, Tomasini, Filippo, de Braud, Benjamin J, Solomon, Daniel, Shao-Weng Tan, Guzmán, Alonso, Jürgen, Wolf, Keunchil, Park, Koichi, Goto, Victoria, Soldatenkova, Sylwia, Szymczak, Scott S, Barker, Tarun, Puri, Aimee, Bence Lin, Herbert, Loong, Benjamin, Besse

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 41(2)

Selpercatinib, a first-in-class, highly selective, and potent CNS-active RET kinase inhibitor, is currently approved for the treatment of patients withPatients were enrolled to LIBRETTO-001, a phase I/II, single-arm, open-label study of selpercatinib

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::765195bda1dd85cefc6dfb87f1c727c7
https://pubmed.ncbi.nlm.nih.gov/36207414

The role of chemotherapy and radiotherapy in localized extraskeletal osteosarcoma

Autor: Marilyn Heng, Abha Gupta, Peter W. Chung, John H. Healey, Max Vaynrub, Peter S. Rose, Matthew T. Houdek, Patrick P. Lin, Andrew J. Bishop, Francis J. Hornicek, Yen-Lin Chen, Santiago Lozano-Calderon, Ginger E. Holt, Ilkyu Han, David Biau, Xiaohui Niu, Nicholas M. Bernthal, Peter C. Ferguson, Jay S. Wunder, Takafumi Ueda, Shigeki Kakunaga, Akira Kawai, Hideshi Sugiura, Teruki Kidani, Toshiyuki Kunisasa, Toshifumi Ozaki, Keisuke Ae, Akihito Nagano, Takatoshi Ohno, Koji Hiraoka, Norio Yamamoto, Hiroyuki Tsuchiya, Yoshihiro Matsumoto, Takashi Yanagawa, Robart Nakayama, Hideo Morioka, Tadahiko Kubo, Shoji Simose, Yoshiki Yamagami, Tetsuji Yamamoto, Motohiro Kawasaki, Tomoaki Torigoe, Yasuo Yazawa, Toru Akiyama, Tabu Gokita, Jun Manabe, Mitsunori Kaya, Makoto Emori, Tomoki Nakamura, Akihiko Matsumine, Shinsuke Sugihara, Masahiro Yokouchi, Setsuro Komiya, Yoshiyuki Suehara, Tatsuya Takagi, Teruya Kawamoto, Junji Wasa, Tsukasa Yonemoto, Takeshi Ishii, Ichiro Baba, Manabu Hoshi, Kenichiro Hamada, Norifumi Naka, Tsukasa Sotobori, Nobuhito Araki, Tomotake Okuma, Takahiro Goto, Hiroshi Kobayashi, Hirotaka Kawano, Masami Hosaka, Hiroyuki Futani, Hiroaski Hiraga, Yoshihiro Nishida, Anthony Griffin, Albiruni R.Abdul Razak, David Benjamin Shultz, Charles Catton, Steven Robinson, Shreyaskumar R. Patel, Valerae O. Lewis, B. Ashleigh Guadagnolo, Thomas DeLaney, Haotong Wang, Kevin Raskin, Alexandra K. Callan, Robert Henshaw, Marc Isler, Sophie Mottard, Wei-Ming Chen, Frank Traub, Tom Wei-Wu Chen, Robert E. Turcotte, Darin Davidson, Per-Ulf Tunn, Herbert Loong, Michelle Ghert, Joel Werier, Paul Clarkson, John A. Abraham

Publikováno v: Eur J Cancer

Purpose The role of chemotherapy (CT) and radiotherapy (RT) for management of extraskeletal osteosarcoma (ESOS) remains controversial. We examined disease outcomes for ESOS patients and investigated the association between CT/RT with recurrence and s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a997f1a26c6656bd43f2838eb237005
https://doi.org/10.1016/j.ejca.2019.07.029

Comprehensive Characterization of the Genomic Landscape in Chinese Pulmonary Neuroendocrine Tumors Reveals Prognostic and Therapeutic Markers (CSWOG-1901)

Autor: Wenying Peng, Liming Cao, Likun Chen, Gen Lin, Bo Zhu, Xiaohua Hu, Yingcheng Lin, Sheng Zhang, Meilin Jiang, Jingyi Wang, Junjun Li, Chao Li, Lin Shao, Haiwei Du, Ting Hou, Zhiqiu Chen, Jianxing Xiang, Xingxiang Pu, Jia Li, Fang Xu, Herbert Loong, Lin Wu

Publikováno v: The oncologist. 27(2)

BackgroundPulmonary neuroendocrine tumors (pNETs) include typical carcinoid (TC), atypical carcinoid (AC), large cell neuroendocrine carcinoma (LCNEC), and small cell lung carcinoma (SCLC). The optimal treatment strategy for each subtype remains elus

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6509f5e7b7a59fcc1fd310c2b9b4fe8f
https://pubmed.ncbi.nlm.nih.gov/35641209

Combining chemotherapy with epidermal growth factor receptor inhibition in advanced non-small cell lung cancer

Autor: Linda Leung, Tony S.K. Mok, Herbert Loong

Publikováno v: Therapeutic Advances in Medical Oncology, Vol 4 (2012)

Treatment of advanced stage lung cancer is changing rapidly. With the new found knowledge on molecular targets such as the epidermal growth factor receptor (EGFR), effective therapy is now available in a selected population with the target mutation.

Externí odkaz: https://doaj.org/article/bf0671bd964d45f1a7f0d5c9a4344757